Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer.
Zhu, Yezi
Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer. [electronic resource] - European urology 05 2018 - 727-735 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1873-7560
10.1016/j.eururo.2017.08.009 doi
Aged
Androgen Antagonists--therapeutic use
Biopsy, Needle
Disease-Free Survival
Humans
Immunohistochemistry
In Situ Hybridization--methods
Logistic Models
Male
Middle Aged
Multivariate Analysis
Neoplasm Invasiveness--pathology
Neoplasm Metastasis
Neoplasm Staging
Prognosis
Prostatic Neoplasms, Castration-Resistant--drug therapy
Protein Isoforms--genetics
Receptors, Androgen--genetics
Survival Analysis
Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer. [electronic resource] - European urology 05 2018 - 727-735 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1873-7560
10.1016/j.eururo.2017.08.009 doi
Aged
Androgen Antagonists--therapeutic use
Biopsy, Needle
Disease-Free Survival
Humans
Immunohistochemistry
In Situ Hybridization--methods
Logistic Models
Male
Middle Aged
Multivariate Analysis
Neoplasm Invasiveness--pathology
Neoplasm Metastasis
Neoplasm Staging
Prognosis
Prostatic Neoplasms, Castration-Resistant--drug therapy
Protein Isoforms--genetics
Receptors, Androgen--genetics
Survival Analysis